Effect of certain drugs on perfused human placenta. IX. Mode of action of angiotensin.
D000804:Angiotensin II / Q000037:antagonists & inhibitors / Q000494:pharmacology*; D001808:Blood Vessels / Q000187:drug effects*; D003250:Constriction; D004176:Dipyridamole / Q000494:pharmacology; D004983:Ethanolamines / Q000494:pharmacology; D005260:Female; D006801:Humans; D006830:Hydralazine / Q000494:pharmacology; D066298:In Vitro Techniques; D007545:Isoproterenol / Q000494:pharmacology; D009119:Muscle Contraction / Q000187:drug effects; D009130:Muscle, Smooth / Q000187:drug effects*; D009573:Nitrites / Q000494:pharmacology; D005996:Nitroglycerin / Q000494:pharmacology; D010477:Perfusion; D010643:Phenoxybenzamine / Q000494:pharmacology; D010646:Phentolamine / Q000494:pharmacology; D010920:Placenta / Q000187:drug effects*; D011247:Pregnancy; D014043:Tolazoline / Q000494:pharmacology
D004983:Ethanolamines; D009573:Nitrites; D010643:Phenoxybenzamine; D000804:Angiotensin II; D006830:Hydralazine; D004176:Dipyridamole; D014043:Tolazoline; D005996:Nitroglycerin; D007545:Isoproterenol; D010646:Phentolamine